Jefferies Financial Group assumed coverage on shares of USANA Health Sciences (NYSE:USNA) in a research note released on Thursday, 24/7 WallStreet reports. The firm issued a hold rating and a $65.00 price target on the stock.
Several other brokerages also recently weighed in on USNA. Pivotal Research reiterated a buy rating on shares of USANA Health Sciences in a report on Wednesday, July 24th. TheStreet downgraded USANA Health Sciences from a b- rating to a c+ rating in a report on Thursday, July 11th. ValuEngine upgraded USANA Health Sciences from a sell rating to a hold rating in a report on Thursday, August 1st. Finally, Sidoti cut shares of USANA Health Sciences from a buy rating to a neutral rating and set a $70.00 price objective for the company. in a research note on Wednesday, July 3rd. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus target price of $70.00.
Shares of USNA opened at $64.29 on Thursday. The stock has a fifty day moving average of $64.96 and a two-hundred day moving average of $80.58. The company has a market capitalization of $1.50 billion, a PE ratio of 12.46 and a beta of 0.44. USANA Health Sciences has a fifty-two week low of $58.30 and a fifty-two week high of $134.65.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Tower Research Capital LLC TRC purchased a new stake in shares of USANA Health Sciences during the 2nd quarter valued at $27,000. Royce & Associates LP grew its stake in shares of USANA Health Sciences by 66.4% during the 1st quarter. Royce & Associates LP now owns 381 shares of the company’s stock valued at $32,000 after buying an additional 152 shares during the period. LS Investment Advisors LLC purchased a new stake in shares of USANA Health Sciences during the 2nd quarter valued at $32,000. Advisory Services Network LLC purchased a new stake in shares of USANA Health Sciences during the 2nd quarter valued at $65,000. Finally, NEXT Financial Group Inc purchased a new stake in shares of USANA Health Sciences during the 2nd quarter valued at $79,000. 66.39% of the stock is owned by institutional investors.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Further Reading: What is the Coverage Ratio?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.